EN
HI

Auro Laboratories Share price

AUROLAB

275.9

6.75 (2.51%)
Last updated on 29 Jul, 2025 | 15:13 IST
BUYSELL
Today's High

278.95

Today's Low

264.40

52 Week Low

156.40

52 Week High

303.00

The current prices are delayed, login to your account for live prices

Auro Laboratories Chart

Auro Laboratories Share Key Metrics

Volume
3585.00
Market Cap
167.75 CR
LTQ@LTP
1@275.90
ATP
272.93
Var Margin
25 %
Circuit Range
215.35-322.95
Delivery %
0 %
Value
9.78 L
ASM/GSM
No
Market Lot
1

Auro Laboratories Futures & Options

Data Not Found

Auro Laboratories Corporate Actions

DateAgenda
2025-05-30Audited Results
2025-05-23Audited Results
2025-02-14Quarterly Results
DateRecord Date
No Data Found

Auro Laboratories News

No Data Found

About Auro Laboratories

NSE : 0  
BSE : 530233  
ISIN : INE292C01011  

Auro Laboratories Limited was incorporated as a PrivateLimited Company on 26th May 1989 with the Registrar ofCompanies Maharashtra at Bombay. Later on the Company hasbeen converted into a Limited Company on 13th January 1994vide resolution dated 21st September 1993. The Company ispromoted by Shri Sharat Deorah and Shri Satish Deorah.After incorporation the Company took all effective steps toset up the manufacturing facilities at Tarapur Maharashtraby acquiring on lease a suitable plot of land at MIDCIndustrial Area and with the aid of State Industrial &Investment Corporation of Maharashtra (SICOM) & MaharashtraState Finance Corporation (MSFC). The Company wassuccessful in implementing the project and started itscommercial production on 14th July 1992. The Company isengaged in the manufacturing and trading of TRIMETHOPRIM(lP/BP/USP) a bulk drug. TMP is an antibacterial drug andis used in combination with SULPHAMETHOXAZOLE (SMX). Theplant of the Company is located at K-56 MIDC IndustrialArea Tarapur Boisar Dist. Thane Maharashtra withproduction capacity of 60 TPA of TMP. The Company ismanaged by the Board of Directors which includes wellexperienced businessmen and professionals Shri SharatDeorah the Promoter-Director of the Company is theManaging Director. He possesses experience of variousbusiness activities for more than 2 decades. This includesroad transport tea warehousing and manufacturing andexports of bulk drugs. Shri Satish Deorah is the youngerbrother of Shri Sharat Deorah. He too holds experiencespanning over more than 17 years in the business activitiesof transport tea warehousing and manufacturing and exportsof bulk drugs. Shri Sharat Deorah is stationed at Bombaywhereas Shri Satish Deorah at Calcutta.The Company is now planning to undertake the project forexpansion of production capacity of TMP from the existing60 TPA to 200 TPA. Besides the Company is also planningfor backward integration by commencing the production of3-4-5 TRIMETHOXYBENZALDEHYDE (TMBA) which is the basic rawmaterial for the production of TMP. The Company has alreadyreceived the Letter of Intent for the production of 3-4-5TMBA vide the Letter of Secretariat for IndustrialApprovals Dept. of Industrial Development Ministry ofIndustry Govt. of India bearing No. LI:34 (1994) dated11th January 1994. The Company has further made anapplication to the Central Government for the amendment ofthe licence with respect to increase in the productioncapacity of 3-4-5 TMBA. The plant will have a capcity of175 TPA of the production of 3-4-5 TMBA from 275 TPA ofGallic Acid which will be consumed entirely by theCompany. Out of the total production 50% of TMP would beexported During the year 1993-94 the Company made exportworth Rs. 45 lacs and is planning to achieve an exporttarget of Rs. 1.50 crores during the current year.So far the Company has been involved in the manufacturingand trading of TMP a bulk drug. One of the groupcompanies Auro Impex Private Limited has a very successfultrack record in the exports of bulk drug items. With a viewto reap benefits of the backward integration the Companyis now planning to commence manufacturing of 3-4-5 TMBA.MAIN OBJECTSThe main objects of the Company as set out in itsMemorandum of Association are as follows :1. To manufacture process derive buy sell importexport or otherwise deal in pharmaceutical medicinaldiagnostic antibiotic antiseptic disinfectants opticalbiological immunological therapeutic and healthcareproducts preparations compounds and intermediates.2. To manufacture process derive buy sell importexport or otherwise deal in cosmetics whether herbal orotherwise hair skin nail or other beauty preparationsperfumes aromatic chemicals toiletories deodorants hairdyes and hygienic house hold consumer products.

Auro Laboratories Management

NamePosition
Mr. Sharat Deorah Chairman & Managing Director
Mr. Siddhartha Deorah Whole Time Director
Mr. Kiran Suresh Kulkarni Whole Time Director
Mrs. Kavita Vijayakant Sharma Ind. Non-Executive Director
Mr. Vishal Kailashchandra Jhunjhunwala Ind. Non-Executive Director
Read More

Auro Laboratories FAQs

The Buying Price of Auro Laboratories share is 275.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Auro Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Auro Laboratories, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Auro Laboratories shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Auro Laboratories shares is 0. Useful to assess the stock's value relative to its book value.

To assess Auro Laboratories’s valuation compare Sector P/E, P/B which are 35.47 & 3.86 with sector averages, along with growth rates and financial metrics.

The Market Cap of Auro Laboratories is 167.75 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Auro Laboratories share price is 303.00 & 156.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.